- Type / Class
- Equity / Common Stock
- Shares outstanding
- 235,704,040
- Total 13F shares
- 9,476,278
- Share change
- -46,920
- Total reported value
- $68,659,000
- Price per share
- $7.24
- Number of holders
- 18
- Value change
- +$188,653
- Number of buys
- 8
- Number of sells
- 14
Quarterly Holders Quick Answers
What is CUSIP 000899104?
CUSIP 000899104 identifies ADMA - ADMA BIOLOGICS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 000899104:
Top shareholders of ADMA - ADMA BIOLOGICS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Aisling Capital LLC |
13F
|
Company |
1.5%
|
3,608,171
|
$21,469,000 | — | 30 Jun 2016 | |
| Biomark Capital Management Co. LLC |
13F
|
Company |
0.61%
|
1,433,304
|
$9,302,000 | — | 30 Jun 2016 | |
| Consonance Capital Management LP |
13F
|
Company |
0.54%
|
1,273,933
|
$7,580,000 | — | 30 Jun 2016 | |
| Broadfin Capital, LLC |
13F
|
Company |
0.47%
|
1,113,293
|
$6,624,000 | — | 30 Jun 2016 | |
| FMR LLC |
13F
|
Company |
0.18%
|
423,100
|
$2,517,000 | — | 30 Jun 2016 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.17%
|
398,394
|
$2,371,000 | — | 30 Jun 2016 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.15%
|
359,499
|
$2,139,000 | — | 30 Jun 2016 | |
| J. Goldman & Co LP |
13F
|
Company |
0.06%
|
143,769
|
$855,000 | — | 30 Jun 2016 | |
| Weiss Multi-Strategy Advisers LLC |
13F
|
Company |
0.06%
|
142,155
|
$846,000 | — | 30 Jun 2016 | |
| Iguana Healthcare Management, LLC |
13F
|
Company |
0.05%
|
125,000
|
$744,000 | — | 30 Jun 2016 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.05%
|
120,959
|
$720,000 | — | 30 Jun 2016 | |
| SABBY MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
100,000
|
$595,000 | — | 30 Jun 2016 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.03%
|
75,000
|
$446,000 | — | 30 Jun 2016 | |
| Telemetry Investments, L.L.C. |
13F
|
Company |
0.02%
|
50,000
|
$298,000 | — | 30 Jun 2016 | |
| PURA VIDA INVESTMENTS, LLC |
13F
|
Company |
0.02%
|
36,500
|
$217,000 | — | 30 Jun 2016 | |
| Spark Investment Management LLC |
13F
|
Company |
0.01%
|
31,300
|
$186,000 | — | 30 Jun 2016 | |
| GUGGENHEIM CAPITAL LLC |
13F
|
Company |
0.01%
|
29,747
|
$177,000 | — | 30 Jun 2016 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.01%
|
18,100
|
$108,000 | — | 30 Jun 2016 | |
| RAYMOND JAMES & ASSOCIATES |
13F
|
Company |
0%
|
10,891
|
$65,000 | — | 30 Jun 2016 | |
| BlackRock Fund Advisors |
13F
|
Company |
0%
|
9,677
|
$58,000 | — | 30 Jun 2016 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
9,152
|
$55,000 | — | 30 Jun 2016 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0%
|
4,684
|
$27,000 | — | 30 Jun 2016 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
3,000
|
$18,000 | — | 30 Jun 2016 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
1,402
|
$9,000 | — | 30 Jun 2016 | |
| Walleye Trading LLC |
13F
|
Company |
0%
|
1,300
|
$8,000 | — | 30 Jun 2016 | |
| BlackRock Investment Management, LLC |
13F
|
Company |
0%
|
708
|
$4,000 | — | 30 Jun 2016 | |
| UBS Group AG |
13F
|
Company |
0%
|
160
|
$1,000 | — | 30 Jun 2016 |
Institutional Holders of ADMA BIOLOGICS, INC. - Common Stock (ADMA) as of Q3 2016
As of 30 Sep 2016,
ADMA BIOLOGICS, INC. - Common Stock (ADMA) was held by
18 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,476,278 shares.
The largest 10 holders included
Aisling Capital LLC, Biomark Capital Management Co. LLC, Consonance Capital Management LP, Broadfin Capital, LLC, PERCEPTIVE ADVISORS LLC, FMR LLC, FRANKLIN RESOURCES INC, Iguana Healthcare Management, LLC, VANGUARD GROUP INC, and Weiss Multi-Strategy Advisers LLC.
This page lists
18
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2016 vs Q2 2016 Across Filers
Q2 2016 holders
27
Q3 2016 holders
18
Holder diff
-9
| Investor | Q2 2016 Shares | Q3 2016 Shares | Share Diff | Share Chg % | Q2 2016 Value $ | Q3 2016 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.